Quorum sensing inhibitors from the sea discovered using bacterial N-acyl-homoserine lactone-based biosensors

Marine Drugs

Volumn 15, Issue 3, 2017, Pages

  Kumar, Saurav ^a   Costantino, Valeria ^b   Venturi, Vittorio ^c   Steindler, Laura ^a  

^a UNIVERSITY OF HAIFA   (Israel)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Antimicrobial resistance; Marine natural products; N acyl homoserine lactones; Quorum quenching; Quorum sensing inhibitors

Indexed keywords

2,3 METHYL N (2' PHENYLETHYL)BUTYRAMIDE; 8 EPI MALYNGAMIDE C; ACULENE C; ACULENE E; ASPERGILLUMARIN A; ASPERGILLUMARIN B; BETA GALACTOSIDASE; CEMBRANOID; COMPOUNDS ACCORDING TO CHEMICAL STRUCTURE; DIPEPTIDE; GREEN FLUORESCENT PROTEIN; HONAUCIN A; ISETHIONIC ACID; KOJIC ACID; LYNGBYOIC ACID; MALYNGAMIDE C; MALYNGOLIDE; MELEAGRIN; N (2' PHENYLETHYL)ISOBUTYRAMIDE; N ACYLHOMOSERINE LACTONE; PENICITOR B; PHENETHYLAMIDE; PHENYLALANINE; PIGMENT; PIPERAZINEDIONE; PITINOIC ACID A; TUMONOIC ACID; TYROSOL; TYROSOL ACETATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; GAMMA BUTYROLACTONE; GAMMA BUTYROLACTONE DERIVATIVE; HOMOSERINE LACTONE;

ALGA; ANTIMICROBIAL ACTIVITY; BACTERIAL VIRULENCE; BIOASSAY; BIOLUMINESCENCE; BIOSENSOR; BRYOZOA; CHEMICAL STRUCTURE; CNIDARIA; CYANOBACTERIUM; HUMAN; ISOLATION PROCEDURE; MARINE ENVIRONMENT; MARINE SPECIES; METABOLITE; NONHUMAN; PIGMENTATION; PROTEIN EXPRESSION; QUORUM SENSING; REVIEW; SEA; SPECIES COMPARISON; SPONGE (PORIFERA); WNT SIGNALING PATHWAY; ANALOGS AND DERIVATIVES; ANIMAL; AQUATIC SPECIES; BACTERIUM; CHEMISTRY; DRUG EFFECTS; FUNGUS; GENETIC PROCEDURES; PROCEDURES; SIGNAL TRANSDUCTION;

4-BUTYROLACTONE; ACYL-BUTYROLACTONES; ANIMALS; ANTI-BACTERIAL AGENTS; AQUATIC ORGANISMS; BACTERIA; BIOLOGICAL PRODUCTS; BIOSENSING TECHNIQUES; FUNGI; HUMANS; QUORUM SENSING; SIGNAL TRANSDUCTION;

EID: 85016463410     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md15030053     Document Type: Review

References (118)

1. Arias, C.A.; Murray, B.E. Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti Infect. Ther. 2008, 6, 637-655. [CrossRef] [PubMed]
2. Yong, D.; Toleman, M.A.; Giske, C.G.; Cho, H.S.; Sundman, K.; Lee, K.; Walsh, T.R. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 2009, 53, 5046-5054. [CrossRef] [PubMed]
3. Furuya, E.Y.; Lowy, F.D. Antimicrobial-resistant bacteria in the community setting. Nat. Rev. Microbiol. 2006, 4, 36-45. [CrossRef] [PubMed]
4. Appelbaum, P.C. 2012 and beyond: Potential for the start of a second pre-Antibiotic era J. Antimicrob. Chemother. 2012, 67, 2062-2068. [CrossRef] [PubMed]
5. Arias, C.A.; Murray, B.E. The rise of the Enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 2012, 10, 266-278. [CrossRef] [PubMed]
6. Dijkshoorn, L.; Nemec, A.; Seifert, H. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5, 939-951. [CrossRef] [PubMed]
7. Otto, M. Staphylococcus epidermidis-The 'accidental' pathogen. Nat. Rev. Microbiol. 2009, 7, 555-567. [CrossRef] [PubMed]
8. Martinez, J.L.; Baquero, F. Interactions among strategies associated with bacterial infection: Pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 2002, 15, 647-679. [CrossRef] [PubMed]
9. Hancock, R.E.W.; Nijnik, A.; Philpott, D.J. Modulating immunity as a therapy for bacterial infections. Nat. Rev. Microboil. 2012, 10, 243-254. [CrossRef] [PubMed]
10. Rasko, D.A.; Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 2010, 9, 117-128. [CrossRef] [PubMed]
11. Winzer, K.; Hardie, K.R.;Williams, P. Bacterial cell-To-cell communication: Sorry, can't talk now-Gone to lunch! Curr. Opin. Microbiol. 2002, 5, 216-222. [CrossRef]
12. Rutherford, S.T.; Bassler, B.L. Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control. Cold Spring Harb. Perspect. Med. 2012, 2, a012427. [CrossRef] [PubMed]
13. Bhardwaj, A.K.; Vinothkumar, K.; Rajpara, N. Bacterial quorum sensing inhibitors: Attractive alternatives for control of infectious pathogens showing multiple drug resistance. Recent Pat. Anti Infect. Drug Discov. 2013, 8, 68-83. [CrossRef]
14. Fuqua, C.; Greenberg, E.P. Listening in on bacteria: Acyl-homoserine lactone signalling. Nat. Rev. Mol. Cell Biol. 2002, 3, 685-695. [CrossRef] [PubMed]
15. Bhavsar, A.P.; Guttman, J.A.; Finlay, B.B. Manipulation of host-cell pathways by bacterial pathogens. Nature 2007, 449, 827-834. [CrossRef] [PubMed]
16. LaSarre, B.; Federle, M.J. Exploiting Quorum Sensing To Confuse Bacterial Pathogens. Microbiol. Mol. Biol. Rev. 2013, 77, 73-111. [CrossRef] [PubMed]
17. Smith, J.M.; Harper, D. Animal Signals; OUP Oxford: New York, NY, USA, 2003.
18. Allen, R.C.; Popat, R.; Diggle, S.P.; Brown, S.P. Targeting virulence: Can we make evolution-proof drugs Nat. Rev. Microboil. 2014, 12, 300-308. [CrossRef] [PubMed]
19. Defoirdt, T.; Boon, N.; Bossier, P. Can Bacteria Evolve Resistance to Quorum Sensing Disruption PLoS Pathog. 2010, 6, e1000989. [CrossRef] [PubMed]
20. Kohler, T.; Perron, G.G.; Buckling, A.; van Delden, C. Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog. 2010, 6, e1000883. [CrossRef] [PubMed]
21. Wang, M.; Schaefer, A.L.; Dandekar, A.A.; Greenberg, E.P. Quorum sensing and policing of Pseudomonas aeruginosa social cheaters. Proc. Natl. Acad. Sci. USA 2015, 112, 2187-2191. [CrossRef] [PubMed]
22. Mellbye, B.; Schuster, M. The sociomicrobiology of antivirulence drug resistance: A proof of concept. MBio 2011, 2, e00131. [CrossRef] [PubMed]
23. Maeda, T.; Garcia-Contreras, R.; Pu, M.; Sheng, L.; Garcia, L.R.; Tomas, M.; Wood, T.K. Quorum quenching quandary: Resistance to antivirulence compounds. ISME J. 2012, 6, 493-501. [CrossRef] [PubMed]
24. Kwan, J.C.; Meickle, T.; Ladwa, D.; Teplitski, M.; Paul, V.; Luesch, H. Lyngbyoic acid, a "tagged" fatty acid from a marine cyanobacterium, disrupts quorum sensing in Pseudomonas aeruginosa. Mol. Biosyst. 2011, 7, 1205-1216. [CrossRef] [PubMed]
25. Skindersoe, M.E.; Ettinger-Epstein, P.; Rasmussen, T.B.; Bjarnsholt, T.; de Nys, R.; Givskov, M. Quorum Sensing Antagonism from Marine Organisms. Mar. Biotechnol. 2008, 10, 56-63. [CrossRef] [PubMed]
26. Chong, Y.M.; Yin, W.F.; Ho, C.Y.; Mustafa, M.R.; Hadi, A.H.A.; Awang, K.; Narrima, P.; Koh, C.-L.; Appleton, D.R.; Chan, K.-G. Malabaricone C from Myristica cinnamomea Exhibits Anti-Quorum Sensing Activity. J. Nat. Prod. 2011, 74, 2261-2264. [CrossRef] [PubMed]
27. Koh, C.-L.; Sam, C.-K.; Yin,W.-F.; Tan, L.Y.; Krishnan, T.; Chong, Y.M.; Chan, K.-G. Plant-Derived Natural Products as Sources of Anti-Quorum Sensing Compounds. Sensors 2013, 13, 6217-6228. [CrossRef] [PubMed]
28. Teasdale, M.E.; Donovan, K.A.; Forschner-Dancause, S.R.; Rowley, D.C. Gram-Positive Marine Bacteria as a Potential Resource for the Discovery of Quorum Sensing Inhibitors. Mar. Biotechnol. 2011, 13, 722-732. [CrossRef] [PubMed]
29. Dong, Y.H.; Gusti, A.R.; Zhang, Q.; Xu, J.L.; Zhang, L.H. Identification of quorum-quenching N-Acyl homoserine lactonases from Bacillus species. Appl. Environ. Microbiol. 2002, 68, 1754-1759. [CrossRef] [PubMed]
30. Chen, F.; Gao, Y.; Chen, X.; Yu, Z.; Li, X. Quorum Quenching Enzymes and Their Application in Degrading Signal Molecules to Block Quorum Sensing-Dependent Infection. Int. J. Mol. Sci. 2013, 14, 17477-17500. [CrossRef] [PubMed]
31. Yang, F.;Wang, L.-H.;Wang, J.; Dong, Y.-H.; Hu, J.Y.; Zhang, L.-H. Quorum quenching enzyme activity is widely conserved in the sera of mammalian species. FEBS Lett. 2005, 579, 3713-3717. [CrossRef] [PubMed]
32. Givskov, M.; de Nys, R.; Manefield, M.; Gram, L.; Maximilien, R.; Eberl, L.; Molin, S.; Steinberg, P.D.; Kjelleberg, S. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J. Bacteriol. 1996, 178, 6618-6622. [CrossRef] [PubMed]
33. Nealson, K.H.; Platt, T.; Hastings, J.W. Cellular Control of the Synthesis and Activity of the Bacterial Luminescent System. J. Bacteriol. 1970, 104, 313-322. [PubMed]
34. Steindler, L.; Venturi, V. Detection of quorum-sensing N-Acyl homoserine lactone signal molecules by bacterial biosensors. FEMS Microbiol. Lett. 2007, 266, 1-9. [CrossRef] [PubMed]
35. Teasdale, M.E.; Liu, J.; Wallace, J.; Akhlaghi, F.; Rowley, D.C. Secondary Metabolites Produced by the Marine Bacterium Halobacillus salinus That Inhibit Quorum Sensing-Controlled Phenotypes in Gram-Negative Bacteria. Appl. Environ. Microbiol. 2009, 75, 567-572. [CrossRef] [PubMed]
36. Kong, F.D.; Zhou, L.M.; Ma, Q.Y.; Huang, S.Z.;Wang, P.; Dai, H.F.; Zhao, Y.X. Metabolites with Gram-negative bacteria quorum sensing inhibitory activity from the marine animal endogenic fungus Penicillium sp. SCS-KFD08. Arch. Pharm. Res. 2016, 40, 25-31. [CrossRef] [PubMed]
37. Jha, B.; Kavita, K.; Westphal, J.; Hartmann, A.; Schmitt-Kopplin, P. Quorum Sensing Inhibition by Asparagopsis taxiformis, a Marine Macro Alga: Separation of the Compound that Interrupts Bacterial Communication. Mar. Drugs 2013, 11, 253-265. [CrossRef] [PubMed]
38. Natrah, F.M.I.; Kenmegne, M.M.; Wiyoto, W.; Sorgeloos, P.; Bossier, P.; Defoirdt, T. Effects of micro-Algae commonly used in aquaculture on acyl-homoserine lactone quorum sensing. Aquaculture 2011, 317, 53-57. [CrossRef]
39. Abed, R.M.M.; Dobretsov, S.; Al-Fori, M.; Gunasekera, S.P.; Sudesh, K.; Paul, V.J. Quorum-sensing inhibitory compounds from extremophilic microorganisms isolated from a hypersaline cyanobacterial mat. J. Ind. Microbiol. Biotechnol. 2013, 40, 759-772. [CrossRef] [PubMed]
40. Dobretsov, S.; Teplitski, M.; Bayer, M.; Gunasekera, S.; Proksch, P.; Paul, V.J. Inhibition of marine biofouling by bacterial quorum sensing inhibitors. Biofouling 2011, 27, 893-905. [CrossRef] [PubMed]
41. Dobretsov, S.; Teplitski, M.; Alagely, A.; Gunasekera, S.P.; Paul, V.J. Malyngolide from the cyanobacterium Lyngbya majuscula interferes with quorum sensing circuitry. Environ. Microbiol. Rep. 2010, 2, 739-744. [CrossRef] [PubMed]
42. Peters, L.; König, G.M.; Wright, A.D.; Pukall, R.; Stackebrandt, E.; Eberl, L.; Riedel, K. Secondary Metabolites of Flustra foliacea and Their Influence on Bacteria. Appl. Environ. Microbiol. 2003, 69, 3469-3475. [CrossRef] [PubMed]
43. Quintana, J.; Brango-Vanegas, J.; Costa, G.M.; Castellanos, L.; Arévalo, C.; Duque, C. Marine organisms as source of extracts to disrupt bacterial communication: Bioguided isolation and identification of quorum sensing inhibitors from Ircinia felix. Rev. Bras. Farmacogn. 2015, 25, 199-207. [CrossRef]
44. Manefield, M.;Welch, M.; Givskov, M.; Salmond, G.P.; Kjelleberg, S. Halogenated furanones from the red alga, Delisea pulchra, inhibit carbapenem antibiotic synthesis and exoenzyme virulence factor production in the phytopathogen Erwinia carotovora. FEMS Microbiol. Lett. 2001, 205, 131-138. [CrossRef] [PubMed]
45. Tello, E.; Castellanos, L.; Arevalo-Ferro, C.; Duque, C. Cembranoid diterpenes from the Caribbean sea whip Eunicea knighti. J. Nat. Prod. 2009, 72, 1595-1602. [CrossRef] [PubMed]
46. Tello, E.; Castellanos, L.; Arévalo-Ferro, C.; Duque, C. Disruption in Quorum-Sensing Systems and Bacterial Biofilm Inhibition by Cembranoid Diterpenes Isolated from the Octocoral Eunicea knighti. J. Nat. Prod. 2012, 75, 1637-1642. [CrossRef] [PubMed]
47. Tello, E.; Castellanos, L.; Arevalo-Ferro, C.; Rodríguez, J.; Jiménez, C.; Duque, C. Absolute stereochemistry of antifouling cembranoid epimers at C-8 from the Caribbean octocoral Pseudoplexaura flagellosa. Revised structures of plexaurolones. Tetrahedron 2011, 67, 9112-9121. [CrossRef]
48. Meyer, J.L.; Gunasekera, S.P.; Scott, R.M.; Paul, V.J.; Teplitski, M. Microbiome shifts and the inhibition of quorum sensing by Black Band Disease cyanobacteria. ISME J. 2016, 10, 1204-1216. [CrossRef] [PubMed]
49. Mai, T.; Tintillier, F.; Lucasson, A.; Moriou, C.; Bonno, E.; Petek, S.; Magré, K.; Al Mourabit, A.; Saulnier, D.; Debitus, C. Quorum sensing inhibitors from Leucetta chagosensis Dendy, 1863. Lett. Appl. Microbiol. 2015, 61, 311-317. [CrossRef] [PubMed]
50. Liu, H.B.; Koh, K.P.; Kim, J.S.; Seo, Y.; Park, S. The effects of betonicine, floridoside, and isethionic acid from the red alga Ahnfeltiopsis flabelliformis on quorum-sensing activity. Biotechnol. Bioprocess Eng. 2008, 13, 458-463. [CrossRef]
51. Kim, J.S.; Kim, Y.H.; Seo, Y.W.; Park, S. Quorum sensing inhibitors from the red alga, Ahnfeltiopsis flabelliformis. Biotechnol. Bioprocess. Eng. 2007, 12, 308-311. [CrossRef]
52. Gilson, L.; Kuo, A.; Dunlap, P.V. AinS and a new family of autoinducer synthesis proteins. J. Bacteriol. 1995, 177, 6946-6951. [CrossRef] [PubMed]
53. Hanzelka, B.L.; Parsek, M.R.; Val, D.L.; Dunlap, P.V.; Cronan, J.E.; Greenberg, E.P. Acylhomoserine Lactone Synthase Activity of the Vibrio fischeri AinS Protein. J. Bacteriol. 1999, 181, 5766-5770. [PubMed]
54. McClean, K.H.; Winson, M.K.; Fish, L.; Taylor, A.; Chhabra, S.R.; Camara, M.; Daykin, M.; Lamb, J.H.; Swift, S.; Bycroft, B.W.; et al. Quorum sensing and Chromobacterium violaceum: Exploitation of violacein production and inhibition for the detection of N-Acylhomoserine lactones. Microbiology 1997, 143 Pt 12, 3703-3711. [CrossRef] [PubMed]
55. Martinelli, D.; Grossmann, G.; Sequin, U.; Brandl, H.; Bachofen, R. Effects of natural and chemically synthesized furanones on quorum sensing in Chromobacterium violaceum. BMC Microbiol. 2004, 4, 25. [CrossRef] [PubMed]
56. Bandara, M.B.K.; Zhu, H.; Sankaridurg, P.R.; Willcox, M.D.P. Salicylic Acid Reduces the Production of Several Potential Virulence Factors of Pseudomonas aeruginosa Associated with Microbial Keratitis. Investig. Ophthalmol. Vis. Sci. 2006, 47, 4453-4460. [CrossRef] [PubMed]
57. Chernin, L.S.; Winson, M.K.; Thompson, J.M.; Haran, S.; Bycroft, B.W.; Chet, I.; Williams, P.; Stewart, G.S.A.B. Chitinolytic Activity in Chromobacterium violaceum: Substrate Analysis and Regulation by Quorum Sensing. J. Bacteriol. 1998, 180, 4435-4441. [PubMed]
58. Winson, M.K.; Swift, S.; Fish, L.; Throup, J.P.; Jorgensen, F.; Chhabra, S.R.; Bycroft, B.W.; Williams, P.; Stewart, G.S. Construction and analysis of luxCDABE-based plasmid sensors for investigating N-Acyl homoserine lactone-mediated quorum sensing. FEMS Microbiol. Lett. 1998, 163, 185-192. [CrossRef] [PubMed]
59. Meighen, E.A. Molecular biology of bacterial bioluminescence. Microbiol. Rev. 1991, 55, 123-142. [PubMed]
60. Meighen, E.A.; Szittner, R.B. Multiple repetitive elements and organization of the lux operons of luminescent terrestrial bacteria. J. Bacteriol. 1992, 174, 5371-5381. [CrossRef] [PubMed]
61. Swift, S.; Karlyshev, A.V.; Fish, L.; Durant, E.L.; Winson, M.K.; Chhabra, S.R.; Williams, P.; Macintyre, S.; Stewart, G.S. Quorum sensing in Aeromonas hydrophila and Aeromonas salmonicida: Identification of the LuxRI homologs AhyRI and AsaRI and their cognate N-Acylhomoserine lactone signal molecules. J. Bacteriol. 1997, 179, 5271-5281. [CrossRef] [PubMed]
62. Rasmussen, T.B.; Bjarnsholt, T.; Skindersoe, M.E.; Hentzer, M.; Kristoffersen, P.; Kote, M.; Nielsen, J.; Eberl, L.; Givskov, M. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J. Bacteriol. 2005, 187, 1799-1814. [CrossRef] [PubMed]
63. Henke, J.M.; Bassler, B.L. Three parallel quorum-sensing systems regulate gene expression in Vibrio harveyi. J. Bacteriol. 2004, 186, 6902-6914. [CrossRef] [PubMed]
64. Tsien, R.Y. The green fluorescent protein. Annu. Rev. Biochem. 1998, 67, 509-544. [CrossRef] [PubMed]
65. Riedel, K.; Hentzer, M.; Geisenberger, O.; Huber, B.; Steidle, A.; Wu, H.; Hoiby, N.; Givskov, M.; Molin, S.; Eberl, L. N-Acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 2001, 147, 3249-3262. [CrossRef] [PubMed]
66. Huber, B.; Riedel, K.; Hentzer, M.; Heydorn, A.; Gotschlich, A.; Givskov, M.; Molin, S.; Eberl, L. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 2001, 147, 2517-2528. [CrossRef]
67. Andersen, J.B.; Heydorn, A.; Hentzer, M.; Eberl, L.; Geisenberger, O.; Christensen, B.B.; Molin, S.; Givskov, M. gfp-based N-Acyl homoserine-lactone sensor systems for detection of bacterial communication. Appl. Environ. Microbiol. 2001, 67, 575-585. [CrossRef] [PubMed]
68. Hentzer, M.; Riedel, K.; Rasmussen, T.B.; Heydorn, A.; Andersen, J.B.; Parsek, M.R.; Rice, S.A.; Eberl, L.; Molin, S.; Hoiby, N.; et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 2002, 148, 87-102. [CrossRef] [PubMed]
69. Alam, J.; Cook, J.L. Reporter genes: Application to the study of mammalian gene transcription. Anal. Biochem. 1990, 188, 245-254. [CrossRef]
70. Farrand, S.K.; Qin, Y.; Oger, P. Quorum-sensing system of Agrobacterium plasmids: Analysis and utility. Methods Enzymol. 2002, 358, 452-484. [PubMed]
71. Shaw, P.D.; Ping, G.; Daly, S.L.; Cha, C.; Cronan, J.E.; Rinehart, K.L.; Farrand, S.K. Detecting and characterizing N-Acyl-homoserine lactone signal molecules by thin-layer chromatography. Proc. Natl. Acad. Sci. USA 1997, 94, 6036-6041. [CrossRef] [PubMed]
72. Lu, Y.; Dong, X.; Liu, S.; Bie, X. Characterization and Identification of a Novel Marine Streptomyces sp. Produced Antibacterial Substance. Mar. Biotechnol. 2009, 11, 717-724. [CrossRef] [PubMed]
73. Cragg, G.M.; Newman, D.J. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta 2013, 1830, 3670-3695. [CrossRef] [PubMed]
74. Liu, X.; Ashforth, E.; Ren, B.; Song, F.; Dai, H.; Liu, M.; Wang, J.; Xie, Q.; Zhang, L. Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J. Antibiot. 2010, 63, 415-422. [CrossRef] [PubMed]
75. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2016, 33, 382-431. [CrossRef] [PubMed]
76. Saurav, K.; Kannabiran, K. Diversity and Optimization of Process Parameters for the Growth of Streptomyces VITSVK9 spp Isoled From Bay of Bengal, India. J. Nat. Environ. Sci. 2010, 1, 56-65.
77. Li, M.; Huiru, Z.; Biting, D.; Yun, J.; Wei, J.; Kunming, D. Study on the anti-quorum sensing activity of a marine bacterium Staphylococcus saprophyticus 108. BioTechnology Indian J. 2013, 7, 480-487.
78. Martínez-Matamoros, D.; Fonseca, M.L.; Duque, C.; Ramos, F.A.; Castellanos, L. Screening of marine bacterial strains as source of quorum sensing inhibitors (QSI): First chemical study of Oceanobacillus profundus (RKHC-62B). VITAE 2016, 23, 30-47. [CrossRef]
79. Hasan, S.; Ansari, M.I.; Ahmad, A.; Mishra, M. Major bioactive metabolites from marine fungi: A Review. Bioinformation 2015, 11, 176-181. [CrossRef] [PubMed]
80. Li, X.; Jeong, J.H.; Lee, K.T.; Rho, J.R.; Choi, H.D.; Kang, J.S.; Son, B.W. Gamma-pyrone derivatives, kojic acid methyl ethers from a marine-derived fungus Alternaria [correction of Altenaria] sp. Arch. Pharm. Res. 2003, 26, 532-534. [CrossRef] [PubMed]
81. Zheng, C.J.; Sohn, M.-J.; Lee, S.; Kim, W.-G. Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action. PLoS ONE 2013, 8, e78922. [CrossRef]
82. Miller, B.; Friedman, A.J.; Choi, H.; Hogan, J.; McCammon, J.A.; Hook, V.; Gerwick, W.H. The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L. J. Nat. Prod. 2014, 77, 92-99. [CrossRef] [PubMed]
83. Kleigrewe, K.; Almaliti, J.; Tian, I.Y.; Kinnel, R.B.; Korobeynikov, A.; Monroe, E.A.; Duggan, M.; Di Marzo, V.; Sherman, D.H.; Dorrestein, P.C.; et al. Combining Mass Spectrometric Metabolic Profiling with Genomic Analysis: A Powerful Approach for Discovering Natural Products from Cyanobacteria. J. Nat. Prod. 2015, 78, 1671-1682. [CrossRef] [PubMed]
84. Clark, B.R.; Engene, N.; Teasdale, M.E.; Rowley, D.C.; Matainaho, T.; Valeriote, F.A.; Gerwick,W.H. Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum. J. Nat. Prod. 2008, 71, 1530-1537. [CrossRef] [PubMed]
85. Kwan, J.C.; Teplitski, M.; Gunasekera, S.P.; Paul, V.J.; Luesch, H. Isolation and biological evaluation of 8-epi-malyngamide C from the Floridian marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2010, 73, 463-466. [CrossRef] [PubMed]
86. Choi, H.; Mascuch, S.J.; Villa, F.A.; Byrum, T.; Teasdale, M.E.; Smith, J.E.; Preskitt, L.B.; Rowley, D.C.; Gerwick, L.; Gerwick, W.H. Honaucins A-C, Potent Inhibitors of Eukaryotic Inflammation and Bacterial Quorum Sensing: Synthetic Derivatives and Structure-Activity Relationships. Chem. Biol. 2012, 19, 589-598. [CrossRef] [PubMed]
87. Montaser, R.; Paul, V.J.; Luesch, H. Modular Strategies for Structure and Function Employed by Marine Cyanobacteria: Characterization and Synthesis of Pitinoic Acids. Org. Lett. 2013, 15, 4050-4053. [CrossRef] [PubMed]
88. Mehbub, M.F.; Lei, J.; Franco, C.; Zhang,W. Marine Sponge Derived Natural Products between 2001 and 2010: Trends and Opportunities for Discovery of Bioactives. Mar. Drugs 2014, 12, 4539-4577. [PubMed]
89. Costantino, V.; Fattorusso, E.; Mangoni, A.; Perinu, C.; Cirino, G.; De Gruttola, L.; Roviezzo, F. Tedanol: A potent anti-inflammatory ent-pimarane diterpene from the Caribbean Sponge Tedania ignis. Bioorg. Med. Chem. 2009, 17, 7542-7547. [CrossRef] [PubMed]
90. Teta, R.; Irollo, E.; Della Sala, G.; Pirozzi, G.; Mangoni, A.; Costantino, V. Smenamides A and B, chlorinated peptide/polyketide hybrids containing a dolapyrrolidinone unit from the Caribbean sponge Smenospongia aurea. Evaluation of their role as leads in antitumor drug research. Mar. Drugs 2013, 11, 4451-4463. [CrossRef] [PubMed]
91. Esposito, G.; Teta, R.; Miceli, R.; Ceccarelli, L.S.; Della Sala, G.; Camerlingo, R.; Irollo, E.; Mangoni, A.; Pirozzi, G.; Costantino, V. Isolation and Assessment of the in Vitro Anti-Tumor Activity of Smenothiazole A and B, Chlorinated Thiazole-Containing Peptide/Polyketides from the Caribbean Sponge, Smenospongia aurea. Mar. Drugs 2015, 13, 444-459. [CrossRef] [PubMed]
92. Costantino, V.; Fattorusso, E.; Imperatore, C.; Mangoni, A. Glycolipids from sponges. 20. J-Coupling analysis for stereochemical assignments in furanosides: Structure elucidation of vesparioside B, a glycosphingolipid from the marine sponge Spheciospongia vesparia. J. Org. Chem. 2008, 73, 6158-6165. [CrossRef] [PubMed]
93. Costantino, V.; Fattorusso, E.; Imperatore, C.; Mangoni, A. Ectyoceramide, the First Natural Hexofuranosylceramide from the Marine Sponge Ectyoplasia ferox. Eur. J. Org. Chem. 2003, 2003, 1433-1437. [CrossRef]
94. Martinez, A.; Duque, C.; Hara, N.; Fujimoto, Y. Variabilin 11-Methyloctadecanoate, A Branched-Chain Fatty Acid Ester of Furanosesterterpene Tetronic Acid, from the Sponge Ircinia Felix. Nat. Prod. Lett. 1995, 6, 281-284. [CrossRef]
95. Martinez, A.; Duque, C.; Sato, N.; Fujimoto, Y. (8Z,13Z,20Z)-Strobilinin and (7Z,13Z,20Z)-Felixinin: New Furanosesterterpene Tetronic Acids from Marine Sponges of the Genus Ircinia. Chem. Pharm. Bull. 1997, 45, 181-184. [CrossRef]
96. Saurav, K.; Bar-Shalom, R.; Haber, M.; Burgsdorf, I.; Oliviero, G.; Costantino, V.; Morgenstern, D.; Steindler, L. In Search of Alternative Antibiotic Drugs: Quorum-Quenching Activity in Sponges and their Bacterial Isolates. Front. Microbiol. 2016, 7, 416. [CrossRef] [PubMed]
97. Hardoim, C.C.; Costa, R. Microbial Communities and Bioactive Compounds in Marine Sponges of the Family Irciniidae-A Review. Mar. Drugs 2014, 12, 5089-5122. [CrossRef] [PubMed]
98. Supriyono, A.; Schwarz, B.; Wray, V.; Witte, L.; Muller, W.E.; van Soest, R.; Sumaryono, W.; Proksch, P. Bioactive alkaloids from the tropical marine sponge Axinella carteri. Z. Naturforsch. C 1995, 50, 669-674. [PubMed]
99. Hertiani, T.; Edrada-Ebel, R.; Ortlepp, S.; van Soest, R.W.; de Voogd, N.J.;Wray, V.; Hentschel, U.; Kozytska, S.; Muller, W.E.; Proksch, P. From anti-fouling to biofilm inhibition: New cytotoxic secondary metabolites from two Indonesian Agelas sponges. Bioorg. Med. Chem. 2010, 18, 1297-1311. [CrossRef] [PubMed]
100. Hertiani, T. New hope on drug leads development from deep ocean: Halogenated alkaloids of Agelas sponge. Indones. J. Pharm. 2014, 25, 199-222. [CrossRef]
101. Ebel, R.; Brenzinger, M.; Kunze, A.; Gross, H.J.; Proksch, P. Wound Activation of Protoxins in Marine Sponge Aplysina aerophoba. J. Chem. Ecol. 1997, 23, 1451-1462. [CrossRef]
102. Loïc, G.C.; Leonel, P. Review of Marine Algae as Source of Bioactive Metabolites: A Marine Biotechnology Approach. In Marine Algae; CRC Press: Boca Raton, FL, USA, 2014; pp. 195-227.
103. El Gamal, A.A. Biological importance of marine algae. Saudi Pharm. J. 2010, 18, 1-25. [CrossRef] [PubMed]
104. Pérez, M.J.; Falqué, E.; Domínguez, H. Antimicrobial Action of Compounds from Marine Seaweed. Mar. Drugs 2016, 14, 52. [CrossRef] [PubMed]
105. Michalak, I.; Chojnacka, K. Algae as production systems of bioactive compounds. Eng. Life Sci. 2015, 15, 160-176. [CrossRef]
106. Lee, J.-C.; Hou, M.-F.; Huang, H.-W.; Chang, F.-R.; Yeh, C.-C.; Tang, J.-Y.; Chang, H.-W. Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int. 2013, 13, 55. [CrossRef] [PubMed]
107. Pereira, H.; Barreira, L.; Figueiredo, F.; Custódio, L.; Vizetto-Duarte, C.; Polo, C.; Rešek, E.; Engelen, A.; Varela, J. Polyunsaturated Fatty Acids of Marine Macroalgae: Potential for Nutritional and Pharmaceutical Applications. Mar. Drugs 2012, 10, 1920-1935. [CrossRef] [PubMed]
108. Janczyk, W.; Socha, P.; Lebensztejn, D.; Wierzbicka, A.; Mazur, A.; Neuhoff-Murawska, J.; Matusik, P. Omega-3 fatty acids for treatment of non-Alcoholic fatty liver disease: Design and rationale of randomized controlled trial. BMC Pediatr. 2013, 13, 85. [CrossRef] [PubMed]
109. Dworjanyn, A.S.; De Nys, R.; Steinberg, D.P. Localisation and surface quantification of secondary metabolites in the red alga Delisea pulchra. Mar. Biol. 1999, 133, 727-736. [CrossRef]
110. Delago, A.; Mandabi, A.; Meijler, M.M. Natural Quorum Sensing Inhibitors-Small Molecules, Big Messages. Isr. J. Chem. 2016, 56, 310-320. [CrossRef]
111. Koch, B.; Liljefors, T.; Persson, T.; Nielsen, J.; Kjelleberg, S.; Givskov, M. The LuxR receptor: The sites of interaction with quorum-sensing signals and inhibitors. Microbiology 2005, 151, 3589-3602. [CrossRef] [PubMed]
112. Rocha, J.; Peixe, L.; Gomes, N.C.M.; Calado, R. Cnidarians as a Source of New Marine Bioactive Compounds-An Overview of the Last Decade and Future Steps for Bioprospecting. Mar. Drugs 2011, 9, 1860-1886. [CrossRef] [PubMed]
113. Daly, M.; Brugler, M.R.; Cartwright, P.; Collins, A.G.; Dawson, M.N.; Fautin, D.G.; France, S.C.; McFadden, C.S.; Opresko, D.M.; Rodriguez, E.; et al. The phylum Cnidaria: A review of phylogenetic patterns and diversity 300 years after Linnaeus. Zootaxa 2007, 1668, 127-182.
114. Turk, T.; Kem,W.R. The phylum Cnidaria and investigations of its toxins and venoms until 1990. Toxicon 2009, 54, 1031-1037. [CrossRef] [PubMed]
115. Sharp, J.H.; Winson, M.K.; Porter, J.S. Bryozoan metabolites: An ecological perspective. Nat. Prod. Rep. 2007, 24, 659-673. [CrossRef] [PubMed]
116. Nakao, Y.; Shiroiwa, T.; Murayama, S.; Matsunaga, S.; Goto, Y.; Matsumoto, Y.; Fusetani, N. Identification of Renieramycin A as an Antileishmanial Substance in a Marine Sponge Neopetrosia sp. Mar. Drugs 2004, 2, 55-62. [CrossRef]
117. De Almeida Leone, P.; Carroll, A.R.; Towerzey, L.; King, G.; McArdle, B.M.; Kern, G.; Fisher, S.; Hooper, J.N.A.; Quinn, R.J. Exiguaquinol: A Novel Pentacyclic Hydroquinone from Neopetrosia exigua that Inhibits Helicobacter pylori MurI. Org. Lett. 2008, 10, 2585-2588. [CrossRef] [PubMed]
118. Thale, Z.; Johnson, T.; Tenney, K.; Wenzel, P.J.; Lobkovsky, E.; Clardy, J.; Media, J.; Pietraszkiewicz, H.; Valeriote, F.A.; Crews, P. Structures and Cytotoxic Properties of Sponge-Derived Bisannulated Acridines. J. Org. Chem. 2002, 67, 9384-9391. [CrossRef] [PubMed]